From the middle of next year, means-tested public healthcare subsidy frameworks are set to be revised as government spending on patient subsidies is projected to hit S$6.5 billion in the 2020 financial year, up from S$4 billion five years before.
The changes are warranted because healthcare expenditure is expected to rise over time as well. Singapore’s population is ageing and there is a rising incidence of chronic diseases, while accessibility and quality of care are improving.
To understand the changes in subsidy please read the entire article here originally published in Today Online here.
Image credits: Great Eastern Life
Have anything to say about Singapore’s healthcare subsidy? Please let us know in the Comments Section below.
